TABLE 4.
Prospective case‐control study: Comparison of optical platelet aggregometry variables measured in dogs with SARDS compared to healthy controls.
| Platelet agonist | Variable | SARDS | Controls | P value |
|---|---|---|---|---|
| ADP | Amplitude (%) | 62 (8‐103) | 45 (13‐72) | .42 |
| Slope | 75 (40‐134) | 79 (39‐88) | .26 | |
| Lag (s) | 50 (42‐65) | 52 (40‐62) | .68 | |
| AUC | 240.7 (3.2‐459.3) | 151.9 (30.9‐310.5) | .53 | |
| Collagen | Amplitude (%) | 60 (1‐71) | 7 (1‐79) | .04 |
| Slope | 66 (18‐132) | 18 (11‐116) | .1 | |
| Lag (s) | 128 (16‐360) | 316 (8‐360) | .31 | |
| AUC | 85.4 (0‐208.9) | 7.5 (0‐202.5) | .22 |
Note: Adjusted P value cutoffs are presented in Table S1.
Abbreviations: ADP, adenosine diphosphate; AUC, area under the curve; SARDS, sudden acquired retinal degeneration syndrome.